TRPC3 [83] and TRPC6 [84] have been implicated in DOX-mediated cardiotoxicity, whereas TRPC5 has been associated with P-glycoprotein-induced chemoresistance in cancer cells [85]. Here, TRPC3 is linked to cancer.